BMEA Live signals | Maximize Profits with Getagraph.com

SELL 104049 min ago

@ $16.91

Issued: 13 Feb 2024 @ 15:46

Return: -38.08%

Previous signal: Feb 12 - 12:23

Previous signal: Buy

Return: -5.11 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	497 668
Average Volume	1.05M
Market Cap	370.65M
EPS	$0 ( 2024-04-02 )
Next earnings date	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.64
ATR14	$0.0170 (0.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-17	Butler Thomas Andrew	Buy	407 502	Stock Option (Right to Buy)
2024-01-17	Erdtmann Rainer M	Buy	135 700	Stock Option (Right to Buy)
2024-01-17	Valle Franco	Buy	145 245	Stock Option (Right to Buy)
2024-01-17	Frias Juan Pablo	Buy	111 090	Stock Option (Right to Buy)
2023-12-29	Erdtmann Rainer M	Sell	3 000	Common Stock

INSIDER POWER
31.21
Last 86 transactions
Buy: 9 688 408 \| Sell: 6 373 693

Volume Correlation

Long: -0.22 (neutral)

Short: -0.17 (neutral)

Signal:(61.834) Neutral

Biomea Fusion, Inc. Correlation

10 Most Positive Correlations
TZPS	0.935
RAM	0.935
PT	0.935
SVFAU	0.934
COCO	0.928
NAUT	0.926
MLAI	0.924
CERT	0.924
GAINM	0.923
LMB	0.923

10 Most Negative Correlations
MGI	-0.941
NKLA	-0.937
ILPT	-0.932
FCBC	-0.927
LOAN	-0.925
SPFI	-0.924
ALLK	-0.923
RMRM	-0.922
MNDO	-0.922
NKSH	-0.922

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biomea Fusion, Inc. Correlation - Currency/Commodity

-0.38
( neutral )

0.18
( neutral )

0.00
( neutral )

-0.37
( neutral )

-0.29
( neutral )

0.21
( neutral )

Biomea Fusion, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-1.26M (0.00 %)
EPS:	$-2.73

Q3	2023
Revenue:	$0
Gross Profit:	$-1.11M (0.00 %)
EPS:	$-0.800

Q2	2023
Revenue:	$0
Gross Profit:	$-1.06M (0.00 %)
EPS:	$-0.700

Q1	2023
Revenue:	$0
Gross Profit:	$-905 000 (0.00 %)
EPS:	$-0.950

Financial Reports:

No articles found.

Biomea Fusion, Inc.

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.